Nutex Health (NUTX) Non-Current Deffered Revenue (2015 - 2016)
Nutex Health (NUTX) posted Non-Current Deffered Revenue of $497088.0 for Q3 2016, up 9.53% sequentially from $453823.0 in Q2 2016.
Powered by 
Analysis
Nutex Health (NUTX) Non-Current Deffered Revenue (2015 - 2016) Analysis & Trends
Nutex Health has reported Non-Current Deffered Revenue for 2 years, with the latest figure at $497088.0 in Q3 2016.
- Quarterly Non-Current Deffered Revenue changed N/A year-over-year to $497088.0 in Q3 2016, while the trailing twelve-month figure through Sep 2016 was $497088.0 (changed N/A YoY) and the FY2015 annual result came in at $379052.0, changed N/A from the prior year.
- Non-Current Deffered Revenue rose to $497088.0 in Q3 2016 per NUTX's latest filing, from $453823.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $497088.0 in Q3 2016 and troughed at $379052.0 in Q4 2015.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | HCA Healthcare | 90.36 Bn | 89.35 Bn | 15.19 Bn | - |
| 2 | Tenet Healthcare | 22.02 Bn | 19.85 Bn | 4.45 Bn | - |
| 3 | Encompass Health | 12.13 Bn | 11.99 Bn | 1.34 Bn | - |
| 4 | Davita | 11.78 Bn | 11.09 Bn | 1.16 Bn | - |
| 5 | Universal Health Services | 10.09 Bn | 9.95 Bn | 3.29 Bn | - |
| 6 | Ensign | 9.97 Bn | 9.65 Bn | 306.24 Mn | 98.43 Mn |
| 7 | Chemed | 6.93 Bn | 6.89 Bn | 221.47 Mn | 146.99 Mn |
| 8 | Pacs | 6.81 Bn | 6.64 Bn | 338.46 Mn | - |
| 9 | Concentra Group Holdings Parent | 4.32 Bn | 4.16 Bn | 192.10 Mn | - |
| 10 | Nutex Health | 1.36 Bn | 1.15 Bn | 141.28 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2016 | 497,088.00 |
| Jun 30, 2016 | 453,823.00 |
| Mar 31, 2016 | 385,063.00 |
| Dec 31, 2015 | 379,052.00 |